PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Lindane→

Lindane PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
58-89-9
PubChem Substance Record
SID 483925796
Molecular formula
C6H6Cl6
Molecular weight
290.8 g/mol
Drug class
Organochlorine ectoparasiticideGABA-gated chloride-channel antagonist
Mechanism of action
Interferes with neuronal GABA-gated chloride channels in parasites, causing neuronal hyperstimulation and death of lice or mites. Human exposure can cause neurotoxicity; it is a second-line treatment only where still authorised.
Indications / reported uses
  • Historical or second-line treatment of scabies and pediculosis (lice) in selected jurisdictions when safer therapies have failed or are unsuitable; use is restricted because of neurotoxicity and should follow current local regulatory restrictions

Sources: US FDA — Lindane shampoo safety and restrictions · NLM MeSH — Lindane · FDA product information

Identification source: PubChem substance record (SID 483925796; no discrete CID). The linked PubChem record identifies lindane (gamma-hexachlorocyclohexane); it is distinct from technical-grade hexachlorocyclohexane mixtures.

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Lindane PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Lindane Permitted Daily Exposure (PDE) report (the Lindane PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Lindane Occupational Exposure Limit (OEL) report (the Lindane OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.